DekaBank Deutsche Girozentrale’s Natus Medical Inc NTUS Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-20,000	Closed	-$707K	–	1256
2018 Q2	$707K	Hold	20,000	–	–	﹤0.01%	838
2018 Q1	$661K	Buy	20,000 +7,000	+54%	+$222K	﹤0.01%	815
2017 Q4	$444K	Hold	13,000	–	–	﹤0.01%	844
2017 Q3	$444K	Buy	+13,000	New	+$459K	﹤0.01%	850
2015 Q4	–	Sell	-2,460	Closed	-$97K	–	1152
2015 Q3	$97K	Hold	2,460	–	–	﹤0.01%	969
2015 Q2	$105K	Sell	2,460 -15,000	-86%	-$598K	﹤0.01%	1004
2015 Q1	$689K	Buy	17,460 +16,543	+1,804%	+$610K	0.01%	641
2014 Q4	$33K	Buy	+917	New	+$30.8K	﹤0.01%	1047

Other funds holding NTUS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

DekaBank Deutsche Girozentrale's NTUS Position: Q3 2018 in Review

DekaBank Deutsche Girozentrale sold out of Natus Medical Inc (NTUS) in Q3 2018, closing a stake of 20,000 shares — an estimated $707K sold.

DekaBank Deutsche Girozentrale first reported a position in NTUS in Q4 2014 and held it in 8 quarters. The position peaked at $707K in Q2 2018. 176 funds tracked by Wall St. Rank hold NTUS as of Q3 2018.

DekaBank Deutsche Girozentrale reported no remaining Natus Medical Inc position as of Q3 2018 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 20,000 Natus Medical Inc shares in Q3 2018, an estimated $707K.
DekaBank Deutsche Girozentrale first reported a position in Natus Medical Inc in Q4 2014 and held it in 8 quarters.
DekaBank Deutsche Girozentrale's Natus Medical Inc position peaked at $707K in Q2 2018.
176 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2018.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2018, filed 9 Nov 2018.